Secondary sclerosing cholangitis in critically ill patients

Area of Science:

• Hepatology and immunology
• Gastroenterology
• Critical care medicine

Background:

• Primary sclerosing cholangitis (PSC) is a rare idiopathic autoimmune disease causing progressive biliary tree destruction.
• Secondary sclerosing cholangitis (SSC) mimics PSC but results from direct biliary insults like pancreatitis or malignancy.
• A novel form of SSC has emerged following severe critical illness.

Purpose of the Study:

• To describe a newly identified cause of secondary sclerosing cholangitis (SSC).
• To characterize the clinical presentation and progression of this critical illness-associated SSC.
• To highlight the implications for patient management, including liver transplantation.

Main Methods:

• Case series review of patients with SSC following critical illness.
• Analysis of clinical data including respiratory failure, vasopressor use, shock, and sepsis.
• Assessment of disease progression, including development of cirrhosis and need for liver transplantation.

Main Results:

• A distinct SSC subtype was identified in patients recovering from critical illness.
• This SSC form is characterized by rapid progression to cirrhosis.
• Liver transplantation is frequently required for management of this condition.

Conclusions:

• Critical illness-associated SSC represents a significant and aggressive new etiology.
• Early recognition and management are crucial for patients with this condition.
• Further research into the pathogenesis and treatment of this SSC subtype is warranted.